Leading biotech engaged Herspiegel for critical oncology drug launch in a competitive market, showcasing a dedicated, innovative approach.
Menu
Our launch excellence practice was founded to pioneer a model for pharmaceutical product launches that produces consistent predictable success. Experience is our cornerstone, as our collaborative team develops tailored strategies that transcend departmental silos, ensuring seamless alignment and execution to de-risk and accelerate your launch.
Our clients reap the rewards of our extensive experience, with over 125 successful launches. This translates to improved forecast attainment, streamlined processes, and operational excellence. We have assembled a results driven team with expertise in 25+ therapeutic areas, deep scientific understanding, and strong business acumen coupled with strategic insights.
Partner, Launch Excellence Practice Lead
Santosh Naik is a Partner at Herspiegel. He has leveraged his passion for solving critical business issues to advise clients ranging from start-ups to large pharmaceutical and biotechnology firms. He is driven by helping clients develop and execute commercial strategies and solutions that are both realistic and impactful.
While at Herspiegel, Santosh has overseen projects across multiple therapeutic areas including oncology, rare disease, psychiatry, neurology, migraine, women’s health, and pain management. His expertise includes advising clients on brand planning, go-to-market strategy development, and launch readiness and execution. He has advised clients on over 20 unique assets as they prepare for launch.
Prior to joining Herspiegel, Santosh held positions at Forest Labs, later acquired by Actavis, and Becton Dickinson, a leading medical device company. He holds an MBA in pharmaceutical marketing from Rutgers University and a BS in biomedical engineering from Georgia Tech.
